Table 2.
Pathway enrichment analysis.
| Pathway ID: name | Genes counta | % of total Diff. Expr. Genes | p Value | Fold of enrichment |
|---|---|---|---|---|
| hsa04151: PI3K–Akt signaling pathway | 14 | 4.13 | 0.0119 | 2.15 |
| hsa04510: focal adhesion | 13 | 3.83 | <0.001 | 3.35 |
| hsa05205: proteoglycans in cancer | 12 | 3.54 | 0.0012 | 3.19 |
| hsa05203: viral carcinogenesis | 10 | 2.95 | 0.0142 | 2.59 |
| hsa04010: MAPK signaling pathway | 10 | 2.95 | 0.0485 | 2.08 |
| hsa05166: HTLV-I infection | 10 | 2.95 | 0.0495 | 2.08 |
aA threshold of 10 differentially expressed genes per pathway has been applied.